Improving the Informed Consent Process for Infertile Patients Undergoing Assisted Reproductive Technology (ART) With EngagedMD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Patient Satisfaction
- Sponsor
- University of North Carolina, Chapel Hill
- Enrollment
- 100
- Locations
- 3
- Primary Endpoint
- Patient understanding
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The primary purpose of this study is to objectively assess if interactive multimedia tutorials (online videos) enhances patients' comprehensive understanding of assisted reproductive technology (ART) adding EngagedMD, an online library of interactive videos, compared to the traditional process of consent and one-on-one teaching using a 15 question evaluation. The secondary outcome will be to qualitatively assess patients' overall experience of the teaching process comparing the addition of the EngagedMD content to solely traditional teaching for infertility treatment.
Detailed Description
Participants: This will be a multi-center trial with each center planning on recruiting 100 couples. Half of the couples will be planning on undergoing ovulation induction with insemination (OI/IUI) and the other half in-vitro fertilization (IVF). Procedures (methods): This is a multi-center prospective randomized controlled trial where couples undergoing OI/IUI or IVF will be randomized to receiving the current traditional standard of in-person treatment teaching by their physician and nursing team with standard paper consents or to the identical process of in-person teaching with the addition of unrestricted access to the EngagedMD online video resource platform with online consents. Patient demographics, knowledge base, psychological impact of with the treatment, teaching and the consent process and overall satisfaction with the process as a whole will be assessed using surveys administered at three time points throughout the treatment process. A subset of patients that agree will be contacted after the completion of the treatment cycle for a live phone interview.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Female subjects must be 18-49 years of age undergoing fertility treatment
- •Able to give Informed Consent
Exclusion Criteria
- •Patients who do not have adequate command of the English language to provide informed consent
Outcomes
Primary Outcomes
Patient understanding
Time Frame: Each participant will be followed for one treatment cycle, or approximately 2-4 weeks.
Patient understanding of infertility diagnoses and treatment by use of a pre and post test. The test comprises of 15 multiple choice questions and the patients will receive a score of 0-15 and this will be compared as a paired continuous variable from the pre-test score to their post-test score as well as an un-paired continuous variable between the conventional group and the EngagedMD group for pre- and post-test scores as well as delta scores between the two.
Secondary Outcomes
- Patient satisfaction(Each participant will be followed for one treatment cycle, or approximately 2-4 weeks.)